TY - JOUR T1 - Current surge of COVID-19 infection in China and its impact on India. AU - Gupta,Ekta, AU - Samal,Jasmine, AU - Gautam,Pramod, AU - Agarwal,Reshu, Y1 - 2023/02/02/ PY - 2023/1/3/received PY - 2023/1/16/revised PY - 2023/1/19/accepted PY - 2023/3/28/medline PY - 2023/3/26/entrez PY - 2023/3/27/pubmed KW - BF.7 KW - COVID-19 KW - Omicron KW - SARS-CoV-2 SP - 46 EP - 48 JF - Indian journal of medical microbiology JO - Indian J Med Microbiol VL - 42 N2 - BACKGROUND: COVID-19, the pandemic caused by the SARS-CoV-2, is a global health calamity and one of the greatest challenges faced by the humankind across the globe. The virus originated in Wuhan, China and spread rapidly to more than 200 countries/nations, affected more than 600 billion individuals and caused around 65 lakh deaths worldwide. Since the start of the pandemic, SARS-CoV-2 mutates and accumulates genetic variations which constantly resulted in the emergence of new variants. OBJECTIVE: The current article discusses about the new omicron sub variant BF.7, and how this BF.7 variant may pose risk in India, if it overrides the current COVID-19 circulating variants. CONTENT: The emergence and potential consequences of the circulating SARS-CoV-2 variants usually augment virus transmissibility and host immune evasion. The current spurt in COVID-19 infections in China which has alarmed people around the world, is believed to be driven by an omicron sub variant BF.7. Although India has been reporting a "steady decline" in COVID-19 cases, we need constant surveillance to keep a track of the new emerging variants in circulation. Keeping in mind, the new surge in COVID-19 cases across many nations, we discuss about the new variant and its possible impact on India. SN - 1998-3646 UR - https://www.unboundmedicine.com/medline/citation/36967215/Current_surge_of_COVID_19_infection_in_China_and_its_impact_on_India_ DB - PRIME DP - Unbound Medicine ER -